P/E at 64.78 vs Industry's 68.66: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: A Slight Discount in a High-P/E Industry

The hospital sector is characterised by elevated valuations, with an industry P/E of 68.66 reflecting strong investor expectations for growth and profitability. Against this backdrop, Apollo Hospitals Enterprise Ltd. trades at a P/E of 64.78, representing approximately a 5.6% discount to the sector average. This suggests that while the stock commands a premium relative to many broader market segments, it is valued slightly more conservatively within its own industry. Such a valuation differential may imply that investors are pricing in either a marginally slower growth trajectory or a more cautious outlook on near-term earnings expansion. Apollo Hospitals Enterprise Ltd.’s market capitalisation stands at ₹1,29,069.02 crores, firmly placing it in the large-cap category, which often supports premium valuations due to perceived stability and market leadership.

Performance Across Timeframes: Strong Long-Term Gains with Consistent Momentum

Examining the stock’s returns over multiple periods reveals a compelling growth story. Over the past year, Apollo Hospitals Enterprise Ltd. has delivered a robust 25.05% gain, markedly outperforming the Sensex’s 2.46% decline. This outperformance extends over longer horizons as well, with three-year returns at 78.97% versus the Sensex’s 19.24%, five-year returns at 119.53% compared to 44.89%, and an impressive ten-year return of 559.65% against the Sensex’s 180.08%. Such sustained alpha generation underscores the company’s ability to compound value over time.

Shorter-term performance also remains positive, with a three-month return of 14.53% outpacing the Sensex’s 1.02% gain and a year-to-date return of 27.46% versus the Sensex’s 7.72% loss. The stock’s one-month performance of 1.61% slightly exceeds the Sensex’s 0.59% rise, while the one-week return of 0.24% trails the Sensex’s 0.70%. The one-day gain of 1.86% notably outperformed the Sensex’s 0.40% decline, signalling renewed buying interest after two consecutive days of losses. This pattern suggests a resilient momentum profile, although the slight underperformance over the past week invites the question whether this is a temporary consolidation or the start of a more significant correction?

Moving Average Configuration: Bullish Across All Key Averages

The technical setup for Apollo Hospitals Enterprise Ltd. is notably constructive. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, a configuration that typically signals a strong uptrend and broad-based buying support. This alignment across short, medium, and long-term moving averages indicates that the recent gains are supported by sustained momentum rather than a short-lived rally. The proximity to its 52-week high—just 4.19% away from ₹9,326.8—further reinforces the strength of the current trend. The stock’s ability to maintain levels above all major moving averages after a brief two-day dip suggests resilience and a potential continuation of the upward trajectory, although is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Sector Performance Context: Hospital Industry Showing Mixed but Generally Positive Trends

The hospital sector, within which Apollo Hospitals Enterprise Ltd. operates, has experienced a varied performance landscape. While some companies have faced headwinds due to regulatory pressures and rising costs, the sector overall has demonstrated resilience with a majority of stocks posting positive returns in recent quarters. The industry’s elevated P/E ratio of 68.66 reflects investor confidence in the sector’s growth prospects despite these challenges. Within this environment, Apollo Hospitals Enterprise Ltd.’s valuation discount relative to the sector average may be signalling a cautious stance by the market, possibly due to competitive pressures or margin concerns. However, the company’s consistent outperformance across multiple timeframes suggests it remains a key player in the sector’s growth narrative.

Rating Reassessment: Previously Rated Hold, Now Reassessed

On 11 May 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from a previous Hold rating assigned by MarketsMOJO. While the current rating is not disclosed, the reassessment reflects a comprehensive review of the company’s fundamentals, valuation, and technical indicators. The previous Hold rating was based on a Mojo Score of 75.0, indicating a solid but not unequivocal investment case. The updated rating likely incorporates the stock’s strong long-term performance, attractive valuation relative to the sector, and bullish moving average configuration. What is the current rating for Apollo Hospitals Enterprise Ltd. following this reassessment?

Conclusion: Data Reflects a Stock with Strong Long-Term Momentum and a Slight Valuation Discount

The comprehensive data analysis for Apollo Hospitals Enterprise Ltd. reveals a stock that has delivered exceptional long-term returns while maintaining a valuation slightly below its hospital sector peers. Its current trading above all major moving averages and proximity to a 52-week high underscore a robust technical position. The reassessment of its rating from Hold suggests a fresh evaluation of its investment merits, balancing valuation, performance, and sector dynamics. Investors may consider whether to hold, buy more, or reconsider their position in light of this updated rating and the stock’s recent performance trends.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today